Table 1.
Participant characteristics of 853 patients with primary glioma
| Number (%) | |
|---|---|
| Glioma Subtype | |
| High Grade Glioma, NOS | 4 (0.5%) |
| Grade III Mixed Oligodendroglioma | 17 (2.0%) |
| Grade III Pure Oligodendroglioma | 41 (4.8%) |
| Grade III Anaplastic astrocytoma | 117 (13.7%) |
| Grade IV Glioblastoma | 674 (79.0%) |
| Age at diagnosis, years | |
| Mean (SD) | 57 (13.3) |
| Range | 25 – 92 |
| Gender | |
| Male | 506 (59.3%) |
| Female | 347 (40.7%) |
| Race | |
| Caucasian | 804 (94.3%) |
| African American | 43 (5.0%) |
| Asian | 6 (0.7%) |
| Diabetes | |
| Yes | 114 (13.5%) |
| No | 728 (86.5%) |
| KPS | |
| >90 | 98 (13.7%) |
| 70 – 90 | 558 (77.9%) |
| <70 | 60 (8.4%) |
| Standard of Care Treatment | |
| Yes | 615 (72.1%) |
| No | 233 (27.3%) |
| Unknown | 5 (0.6%) |
| Body Mass Index Measures | |
| Recent BMI2, kg/m2, mean (SD) | 27.6 (5.3) |
| Categorical BMI | |
| Underweight (<18.5 kg/m2) | 13 (1.52%) |
| Normal (18.5–24.9 kg/m2) | 251 (29.43%) |
| Overweight (25.0–29.9 kg/m2) | 348 (40.80%) |
| Obese (30.0–39.9 kg/m2) | 216 (25.32%) |
| Morbidly Obese (≥40 kg/m2) | 25 (2.93%) |
| Lifetime Body Weight Measures, mean (SD) | |
| BMI @ age 21 | 22.6 (3.7) |
| Highest lifetime BMI | 30.5 (5.9) |
| Lowest lifetime BMI | 22.5 (3.6) |
| Weight change3 | 33.0 (29.8) |
1
Unequal Ns reflect missing data
2
Based on self-reported weight 1 year (N=103) or 5 years (N=750) prior to glioma diagnosis
3
Weight change in pounds from age 21 to recent pre-diagnostic weight
NOS = not otherwise specified